| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.638 | 0.004 | 0.638 | Calcium channel L-type activator | 0.532 0.017 CID_49838 | ||
| 0.554 | 0.014 | 0.554 | GABA C receptor rho-3 antagonist | 0.311 0.109 CID_49838 | ||
| 0.542 | 0.021 | 0.542 | 5 Hydroxytryptamine release inhibitor | 0.381 0.091 CID_49838 | ||
| 0.528 | 0.023 | 0.528 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.355 0.145 CID_49838 | ||
| 0.507 | 0.032 | 0.507 | Aldehyde oxidase inhibitor | 0.301 0.066 CID_49838 | ||
| 0.511 | 0.056 | 0.511 | Caspase 9 stimulant | 0.405 0.108 CID_49838 | ||
| 0.447 | 0.012 | 0.447 | Calcium channel activator | 0.359 0.044 CID_49838 | ||
| 0.464 | 0.043 | 0.464 | Histamine release inhibitor | 0.31 0.119 CID_49838 | ||
| 0.444 | 0.037 | 0.444 | 5 Hydroxytryptamine release stimulant | 0.2 0.121 CID_49838 | ||
| 0.395 | 0.015 | 0.395 | 5 Hydroxytryptamine uptake stimulant | 0.272 0.062 CID_49838 | ||
| 0.397 | 0.021 | 0.397 | Peroxidase inhibitor | 0.191 0.062 CID_49838 | ||
| 0.373 | 0.007 | 0.373 | Neurotrophic factor enhancer | 0.308 0.016 CID_49838 | ||
| 0.386 | 0.021 | 0.386 | Sodium/bile acid cotransporter inhibitor | 0.378 0.025 CID_49838 | ||
| 0.396 | 0.038 | 0.396 | Aryl hydrocarbon receptor agonist | |||
| 0.364 | 0.013 | 0.364 | Tyrosine 3 hydroxylase inhibitor | 0.248 0.07 CID_49838 | ||
| 0.353 | 0.004 | 0.353 | ABCA1 expression enhancer | 0.13 0.024 CID_49838 | ||
| 0.369 | 0.031 | 0.369 | Hypolipemic | 0.265 0.061 CID_49838 | ||
| 0.367 | 0.033 | 0.367 | Superoxide dismutase inhibitor | 0.222 0.096 CID_49838 | ||
| 0.337 | 0.007 | 0.337 | Cystathionine beta-synthase inhibitor | 0.263 0.013 CID_49838 | ||
| 0.326 | 0.005 | 0.326 | Ferrochelatase inhibitor | 0.143 0.041 CID_49838 | ||
| 0.347 | 0.026 | 0.347 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.329 | 0.013 | 0.342 | Alpha-N-acetylglucosaminidase inhibitor | 0.342 0.012 CID_49838 | CID_49838 | |
| 0.318 | 0.01 | 0.318 | Aldehyde dehydrogenase inhibitor | 0.182 0.033 CID_49838 | ||
| 0.297 | 0.004 | 0.297 | Photosensitizer | 0.215 0.01 CID_49838 | ||
| 0.314 | 0.029 | 0.314 | RNA-directed DNA polymerase inhibitor | 0.258 0.045 CID_49838 | ||
| 0.33 | 0.056 | 0.33 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.275 | 0.004 | 0.275 | CYP2A6 inhibitor | 0.097 0.038 CID_49838 | ||
| 0.316 | 0.05 | 0.316 | Insulysin inhibitor | |||
| 0.266 | 0.005 | 0.266 | CF transmembrane conductance regulator agonist | 0.221 0.013 CID_49838 | ||
| 0.293 | 0.035 | 0.293 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.294 | 0.037 | 0.294 | Gastrin inhibitor | 0.286 0.043 CID_49838 | ||
| 0.261 | 0.005 | 0.261 | T cell inhibitor | 0.121 0.014 CID_49838 | ||
| 0.263 | 0.009 | 0.263 | Catenin beta inhibitor | 0.148 0.11 CID_49838 | ||
| 0.263 | 0.011 | 0.263 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.278 | 0.031 | 0.278 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.251 0.042 CID_49838 | ||
| 0.268 | 0.02 | 0.268 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.274 | 0.034 | 0.274 | Non-steroidal antiinflammatory agent | 0.141 0.129 CID_49838 | ||
| 0.261 | 0.022 | 0.261 | Histone acetyltransferase inhibitor | |||
| 0.263 | 0.025 | 0.263 | Nitric-oxide synthase stimulant | 0.228 0.051 CID_49838 | ||
| 0.241 | 0.007 | 0.241 | Estrogen receptor beta antagonist | 0.153 0.015 CID_49838 | ||
| 0.255 | 0.023 | 0.255 | Cytokine production inhibitor | |||
| 0.292 | 0.06 | 0.316 | DNA damaging | 0.316 0.051 CID_49838 | CID_49838 | |
| 0.236 | 0.005 | 0.236 | Phosphodiesterase 3A inhibitor | |||
| 0.283 | 0.057 | 0.283 | Interleukin agonist | 0.215 0.107 CID_49838 | ||
| 0.247 | 0.022 | 0.247 | Heat shock protein 90 antagonist | 0.247 0.021 CID_49838 | ||
| 0.232 | 0.008 | 0.232 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.139 0.095 CID_49838 | ||
| 0.267 | 0.043 | 0.267 | Anesthetic general | 0.242 0.054 CID_49838 | ||
| 0.243 | 0.025 | 0.243 | Succinate dehydrogenase inhibitor | 0.173 0.077 CID_49838 | ||
| 0.328 | 0.113 | 0.328 | 15-Lipoxygenase inhibitor | 0.23 0.182 CID_49838 | ||
| 0.234 | 0.021 | 0.234 | Hexokinase inhibitor | 0.188 0.043 CID_49838 | ||
| 0.25 | 0.038 | 0.25 | LIM domain kinase 1 inhibitor | |||
| 0.302 | 0.09 | 0.302 | Cholesterol antagonist | 0.251 0.124 CID_49838 | ||
| 0.218 | 0.011 | 0.218 | Estrogen antagonist | 0.163 0.019 CID_49838 | ||
| 0.225 | 0.018 | 0.225 | GABA C receptor rho-2 antagonist | |||
| 0.291 | 0.085 | 0.291 | 12-Lipoxygenase inhibitor | |||
| 0.304 | 0.1 | 0.304 | Prostaglandin dehydrogenase inhibitor | |||
| 0.223 | 0.02 | 0.223 | Mannose-6-phosphate isomerase inhibitor | 0.16 0.057 CID_49838 | ||
| 0.298 | 0.095 | 0.382 | Transcription factor NF kappa B inhibitor | 0.382 0.068 CID_49838 | CID_49838 | |
| 0.21 | 0.011 | 0.21 | Porphobilinogen synthase inhibitor | 0.078 0.049 CID_49838 | ||
| 0.232 | 0.033 | 0.232 | Heat shock protein 90 alpha antagonist | 0.167 0.072 CID_49838 | ||
| 0.215 | 0.018 | 0.215 | GABA C receptor agonist | 0.108 0.059 CID_49838 | ||
| 0.258 | 0.062 | 0.32 | DNA synthesis inhibitor | 0.32 0.037 CID_49838 | CID_49838 | |
| 0.227 | 0.032 | 0.227 | NOS3 expression enhancer | 0.142 0.081 CID_49838 | ||
| 0.227 | 0.036 | 0.227 | Cytidine deaminase inhibitor | |||
| 0.303 | 0.113 | 0.466 | Immunosuppressant | 0.466 0.043 CID_49838 | CID_49838 | |
| 0.274 | 0.084 | 0.274 | Lipoxygenase inhibitor | 0.23 0.114 CID_49838 | ||
| 0.198 | 0.009 | 0.198 | Sphingosine 1-phosphate receptor 4 antagonist | 0.159 0.026 CID_49838 | ||
| 0.202 | 0.018 | 0.202 | Carbonic anhydrase XV inhibitor | 0.108 0.058 CID_49838 | ||
| 0.187 | 0.004 | 0.187 | Liver X receptor agonist | 0.044 0.029 CID_49838 | ||
| 0.196 | 0.014 | 0.196 | p38 MAP kinase inhibitor | |||
| 0.211 | 0.029 | 0.251 | ATPase inhibitor | 0.251 0.013 CID_49838 | CID_49838 | |
| 0.267 | 0.086 | 0.3 | Hypoxia-inducible factor 1 alpha inhibitor | 0.3 0.065 CID_49838 | CID_49838 | |
| 0.194 | 0.018 | 0.194 | MAP3K9 inhibitor | |||
| 0.18 | 0.007 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.175 0.009 CID_49838 | ||
| 0.203 | 0.031 | 0.203 | Arachidonic acid antagonist | 0.201 0.032 CID_49838 | ||
| 0.193 | 0.022 | 0.193 | Nav1.6 sodium channel blocker | |||
| 0.174 | 0.004 | 0.174 | Purinergic P2Y14 antagonist | 0.028 0.023 CID_49838 | ||
| 0.222 | 0.054 | 0.222 | Focal adhesion kinase 2 inhibitor | |||
| 0.237 | 0.07 | 0.237 | Neuropeptide Y2 antagonist | |||
| 0.181 | 0.015 | 0.181 | TRPA1 agonist | |||
| 0.18 | 0.015 | 0.18 | Alcohol dehydrogenase inhibitor | 0.096 0.057 CID_49838 | ||
| 0.168 | 0.004 | 0.168 | Liver X receptor antagonist | 0.034 0.018 CID_49838 | ||
| 0.183 | 0.019 | 0.183 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.132 0.033 CID_49838 | ||
| 0.178 | 0.017 | 0.178 | HIV-1 integrase (Overall Integration) inhibitor | 0.099 0.055 CID_49838 | ||
| 0.176 | 0.015 | 0.176 | Creatine kinase inhibitor | 0.146 0.026 CID_49838 | ||
| 0.178 | 0.018 | 0.178 | GABA C receptor antagonist | 0.092 0.091 CID_49838 | ||
| 0.18 | 0.021 | 0.18 | UDP-glucose 4-epimerase inhibitor | 0.178 0.022 CID_49838 | ||
| 0.231 | 0.073 | 0.231 | Cyclic AMP phosphodiesterase inhibitor | 0.163 0.132 CID_49838 | ||
| 0.187 | 0.03 | 0.187 | Toll-Like receptor 2 antagonist | 0.138 0.061 CID_49838 | ||
| 0.16 | 0.004 | 0.16 | Liver X receptor alpha antagonist | 0.034 0.014 CID_49838 | ||
| 0.177 | 0.023 | 0.177 | 5 Hydroxytryptamine 3A agonist | |||
| 0.163 | 0.01 | 0.163 | Histamine N-methyltransferase inhibitor | 0.1 0.046 CID_49838 | ||
| 0.268 | 0.115 | 0.268 | Vasodilator, peripheral | |||
| 0.178 | 0.026 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.222 | 0.07 | 0.222 | Pyruvate kinase inhibitor | |||
| 0.168 | 0.016 | 0.168 | Triose-phosphate isomerase inhibitor | 0.145 0.021 CID_49838 | ||
| 0.178 | 0.027 | 0.178 | Adenylate cyclase stimulant | 0.175 0.03 CID_49838 | ||
| 0.155 | 0.009 | 0.155 | I kappa B kinase 1 inhibitor | |||
| 0.176 | 0.031 | 0.176 | Cathepsin H inhibitor | 0.125 0.069 CID_49838 | ||
| 0.209 | 0.065 | 0.209 | Insulin sensitizer | 0.148 0.136 CID_49838 | ||
| 0.152 | 0.008 | 0.152 | Bromodomain-containing protein 2 inhibitor | |||
| 0.215 | 0.072 | 0.215 | MAP kinase kinase 2 inhibitor | |||
| 0.164 | 0.021 | 0.164 | DNA repair enzyme inhibitor | 0.148 0.033 CID_49838 | ||
| 0.151 | 0.012 | 0.151 | Phenylalanine 4-hydroxylase inhibitor | 0.1 0.026 CID_49838 | ||
| 0.147 | 0.008 | 0.147 | Potassium channel Kv1.5 blocker | |||
| 0.167 | 0.029 | 0.167 | Pregnane X receptor agonist | 0.133 0.092 CID_49838 | ||
| 0.161 | 0.024 | 0.161 | Potassium channel (Ca-activated) activator | |||
| 0.156 | 0.019 | 0.156 | GABA C receptor rho-1 antagonist | |||
| 0.161 | 0.025 | 0.161 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.062 CID_49838 | ||
| 0.155 | 0.02 | 0.155 | Prolactin inhibitor | 0.081 0.08 CID_49838 | ||
| 0.183 | 0.049 | 0.183 | Cyclin-dependent kinase 8 inhibitor | 0.13 0.103 CID_49838 | ||
| 0.139 | 0.007 | 0.139 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.064 CID_49838 | ||
| 0.182 | 0.05 | 0.203 | Melanin inhibitor | 0.203 0.04 CID_49838 | CID_49838 | |
| 0.155 | 0.024 | 0.155 | Nav1.5 sodium channel blocker | |||
| 0.159 | 0.029 | 0.159 | Heat shock protein 70 antagonist | 0.137 0.089 CID_49838 | ||
| 0.175 | 0.045 | 0.175 | Alkaline phosphatase inhibitor | |||
| 0.147 | 0.02 | 0.147 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.104 0.035 CID_49838 | ||
| 0.148 | 0.022 | 0.148 | DOPA decarboxylase inhibitor | 0.1 0.075 CID_49838 | ||
| 0.14 | 0.015 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 CID_49838 | ||
| 0.144 | 0.02 | 0.144 | Acetylcholine release stimulant | |||
| 0.143 | 0.019 | 0.143 | NADH dehydrogenase inhibitor | 0.138 0.021 CID_49838 | ||
| 0.163 | 0.04 | 0.304 | Alkylator | 0.304 0.012 CID_49838 | CID_49838 | |
| 0.176 | 0.054 | 0.176 | Neurotensin receptor agonist | |||
| 0.126 | 0.005 | 0.126 | Phospholipase D inhibitor | 0.082 0.031 CID_49838 | ||
| 0.225 | 0.106 | 0.225 | Transcription factor STAT3 inhibitor | |||
| 0.171 | 0.052 | 0.171 | Activin receptor-like kinase 2 inhibitor | |||
| 0.131 | 0.013 | 0.131 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.146 | 0.028 | 0.146 | Adenylate kinase inhibitor | 0.139 0.031 CID_49838 | ||
| 0.133 | 0.015 | 0.133 | Glutamate release inhibitor | 0.085 0.075 CID_49838 | ||
| 0.129 | 0.012 | 0.129 | Biliverdin reductase inhibitor | 0.101 0.018 CID_49838 | ||
| 0.142 | 0.025 | 0.142 | Protein kinase C delta inhibitor | |||
| 0.193 | 0.077 | 0.193 | I kappa B kinase epsilon inhibitor | |||
| 0.171 | 0.056 | 0.179 | Interferon gamma antagonist | 0.179 0.051 CID_49838 | CID_49838 | |
| 0.122 | 0.007 | 0.122 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.082 0.015 CID_49838 | ||
| 0.13 | 0.015 | 0.131 | Estrogen receptor alpha antagonist | 0.131 0.015 CID_49838 | CID_49838 | |
| 0.119 | 0.005 | 0.119 | Glutamate (mGluR7) antagonist | 0.075 0.034 CID_49838 | ||
| 0.119 | 0.005 | 0.119 | Exportin-1 inhibitor | 0.069 0.045 CID_49838 | ||
| 0.122 | 0.008 | 0.122 | Phosphodiesterase 3B inhibitor | |||
| 0.127 | 0.014 | 0.127 | mTOR complex 2 inhibitor | 0.087 0.052 CID_49838 | ||
| 0.126 | 0.015 | 0.126 | Glycine receptor antagonist | 0.112 0.023 CID_49838 | ||
| 0.247 | 0.137 | 0.247 | Vasodilator, coronary | 0.202 0.18 CID_49838 | ||
| 0.146 | 0.038 | 0.146 | GABA receptor agonist | |||
| 0.15 | 0.041 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.174 | 0.067 | 0.174 | Phospholipase C inhibitor | 0.161 0.086 CID_49838 | ||
| 0.165 | 0.058 | 0.175 | Protein kinase stimulant | 0.175 0.053 CID_49838 | CID_49838 | |
| 0.111 | 0.005 | 0.111 | Calcium channel P-type blocker | 0.074 0.021 CID_49838 | ||
| 0.134 | 0.028 | 0.145 | Anabolic | 0.145 0.021 CID_49838 | CID_49838 | |
| 0.158 | 0.052 | 0.158 | Interleukin 1 antagonist | 0.109 0.106 CID_49838 | ||
| 0.112 | 0.008 | 0.112 | Fatty acid synthase inhibitor | 0.069 0.027 CID_49838 | ||
| 0.108 | 0.004 | 0.108 | Retinoid X receptor agonist | 0.051 0.017 CID_49838 | ||
| 0.132 | 0.028 | 0.132 | Electrolyte absorption antagonist | |||
| 0.108 | 0.005 | 0.108 | Retinoid X alpha receptor agonist | 0.038 0.022 CID_49838 | ||
| 0.239 | 0.135 | 0.239 | Antithrombotic | 0.208 0.168 CID_49838 | ||
| 0.174 | 0.07 | 0.174 | Antipruritic | |||
| 0.148 | 0.045 | 0.208 | Cholesterol synthesis inhibitor | 0.208 0.025 CID_49838 | CID_49838 | |
| 0.11 | 0.007 | 0.11 | Glutamate (mGluR6) antagonist | 0.091 0.015 CID_49838 | ||
| 0.107 | 0.005 | 0.107 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.217 | 0.116 | 0.217 | Transcription factor STAT inhibitor | |||
| 0.115 | 0.014 | 0.115 | Glycine receptor agonist | 0.101 0.02 CID_49838 | ||
| 0.106 | 0.007 | 0.106 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.151 | 0.053 | 0.151 | Cyclooxygenase 2 inhibitor | |||
| 0.115 | 0.019 | 0.115 | Leukotriene synthesis inhibitor | |||
| 0.208 | 0.112 | 0.208 | Cardiotonic | |||
| 0.105 | 0.01 | 0.105 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.031 CID_49838 | ||
| 0.125 | 0.031 | 0.125 | Androgen antagonist | 0.075 0.071 CID_49838 | ||
| 0.11 | 0.016 | 0.11 | Alcohol oxidase inhibitor | 0.093 0.02 CID_49838 | ||
| 0.107 | 0.013 | 0.107 | Phosphodiesterase 4C inhibitor | |||
| 0.155 | 0.062 | 0.155 | Hemostatic | 0.119 0.116 CID_49838 | ||
| 0.153 | 0.06 | 0.153 | Neuropeptide Y1 antagonist | |||
| 0.102 | 0.01 | 0.102 | Heat shock protein 90 beta antagonist | 0.09 0.015 CID_49838 | ||
| 0.113 | 0.022 | 0.113 | CDC25A inhibitor | |||
| 0.098 | 0.007 | 0.098 | Transcription factor RelA inhibitor | 0.072 0.026 CID_49838 | ||
| 0.097 | 0.008 | 0.097 | 5 Hydroxytryptamine 7 agonist | |||
| 0.109 | 0.021 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.08 0.069 CID_49838 | ||
| 0.114 | 0.027 | 0.114 | GABA A receptor agonist | |||
| 0.102 | 0.015 | 0.102 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.134 | 0.048 | 0.204 | Microtubule formation inhibitor | 0.204 0.019 CID_49838 | CID_49838 | |
| 0.144 | 0.059 | 0.144 | Sodium channel (voltage-gated) blocker | |||
| 0.163 | 0.078 | 0.163 | Mcl-1 antagonist | |||
| 0.107 | 0.023 | 0.107 | Thioredoxin reductase inhibitor | 0.088 0.045 CID_49838 | ||
| 0.088 | 0.004 | 0.088 | Alpha 1d adrenoreceptor agonist | |||
| 0.095 | 0.012 | 0.095 | Estrogen receptor beta agonist | 0.046 0.02 CID_49838 | ||
| 0.151 | 0.069 | 0.151 | Cyclooxygenase inhibitor | |||
| 0.147 | 0.065 | 0.147 | Amylase inhibitor | 0.124 0.079 CID_49838 | ||
| 0.091 | 0.01 | 0.094 | Progesterone antagonist | 0.094 0.009 CID_49838 | CID_49838 | |
| 0.096 | 0.015 | 0.096 | Aryl hydrocarbon receptor antagonist | |||
| 0.085 | 0.005 | 0.085 | GABA uptake inhibitor | 0.042 0.023 CID_49838 | ||
| 0.095 | 0.016 | 0.095 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.094 | 0.015 | 0.095 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.095 0.015 CID_49838 | CID_49838 | |
| 0.11 | 0.031 | 0.11 | Glutamate receptor agonist | |||
| 0.166 | 0.088 | 0.166 | CDC-like kinase 4 inhibitor | |||
| 0.101 | 0.024 | 0.101 | Estrogen-related receptor beta agonist | 0.088 0.046 CID_49838 | ||
| 0.084 | 0.008 | 0.084 | Dihydroorotase inhibitor | |||
| 0.12 | 0.044 | 0.12 | Carbonic anhydrase III inhibitor | |||
| 0.126 | 0.049 | 0.126 | Aminopeptidase B inhibitor | |||
| 0.139 | 0.063 | 0.139 | Cyclooxygenase 1 inhibitor | |||
| 0.096 | 0.02 | 0.096 | Vanilloid 4 agonist | 0.071 0.06 CID_49838 | ||
| 0.098 | 0.024 | 0.098 | CC chemokine 5 receptor agonist | |||
| 0.098 | 0.023 | 0.098 | Phosphodiesterase III inhibitor | |||
| 0.138 | 0.064 | 0.138 | NADPH oxidase inhibitor | |||
| 0.139 | 0.064 | 0.139 | Nav1.2 sodium channel blocker | |||
| 0.133 | 0.059 | 0.133 | CC chemokine 6 receptor antagonist | 0.131 0.068 CID_49838 | ||
| 0.147 | 0.073 | 0.147 | MAP kinase 3 inhibitor | |||
| 0.1 | 0.027 | 0.1 | Prostaglandin-E synthase inhibitor | |||
| 0.174 | 0.1 | 0.174 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.124 | 0.05 | 0.124 | MAO A inhibitor | |||
| 0.1 | 0.027 | 0.1 | GABA aminotransferase inhibitor | |||
| 0.169 | 0.097 | 0.169 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.084 | 0.012 | 0.084 | Aconitate hydratase inhibitor | 0.048 0.043 CID_49838 | ||
| 0.124 | 0.053 | 0.124 | Transcription factor STAT6 inhibitor | |||
| 0.074 | 0.004 | 0.074 | Guanylate cyclase inhibitor | 0.065 0.008 CID_49838 | ||
| 0.106 | 0.037 | 0.106 | Catalase inhibitor | |||
| 0.129 | 0.059 | 0.129 | Beta amyloid protein antagonist | |||
| 0.178 | 0.108 | 0.178 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.089 | 0.02 | 0.089 | 5 Hydroxytryptamine 2A agonist | |||
| 0.132 | 0.063 | 0.132 | Vanilloid 1 agonist | |||
| 0.083 | 0.014 | 0.083 | 5 Hydroxytryptamine 2 agonist | |||
| 0.077 | 0.009 | 0.077 | Adenylate cyclase 1 inhibitor | 0.058 0.019 CID_49838 | ||
| 0.119 | 0.051 | 0.119 | 5-Lipoxygenase inhibitor | |||
| 0.135 | 0.067 | 0.135 | MAO inhibitor | |||
| 0.106 | 0.038 | 0.106 | Ornithine decarboxylase inhibitor | 0.092 0.054 CID_49838 | ||
| 0.096 | 0.029 | 0.096 | Dopamine agonist | |||
| 0.12 | 0.053 | 0.12 | Protein kinase C gamma inhibitor | |||
| 0.168 | 0.101 | 0.168 | Psychostimulant | 0.141 0.124 CID_49838 | ||
| 0.098 | 0.032 | 0.098 | Keratolytic | 0.093 0.035 CID_49838 | ||
| 0.215 | 0.149 | 0.215 | Thyroid hormone antagonist | |||
| 0.096 | 0.03 | 0.096 | Aminopeptidase I inhibitor | 0.07 0.054 CID_49838 | ||
| 0.083 | 0.017 | 0.083 | Phosphodiesterase 1C inhibitor | |||
| 0.23 | 0.164 | 0.23 | Calpain 2 inhibitor | |||
| 0.098 | 0.033 | 0.099 | Phosphofructokinase-1 inhibitor | 0.099 0.032 CID_49838 | CID_49838 | |
| 0.105 | 0.04 | 0.105 | Bile acid receptor antagonist | 0.092 0.069 CID_49838 | ||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.088 | 0.024 | 0.088 | Orexin receptor 1 antagonist | |||
| 0.085 | 0.02 | 0.085 | Carbonic anhydrase VB inhibitor | |||
| 0.112 | 0.048 | 0.112 | Hedgehog signaling inhibitor | |||
| 0.209 | 0.146 | 0.209 | Thyroid hormone beta antagonist | |||
| 0.073 | 0.01 | 0.073 | Thymidylate synthase inhibitor | 0.047 0.031 CID_49838 | ||
| 0.097 | 0.034 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.075 | 0.013 | 0.075 | Estrogen receptor alpha agonist | 0.062 0.015 CID_49838 | ||
| 0.076 | 0.013 | 0.076 | DNA helicase inhibitor | 0.051 0.048 CID_49838 | ||
| 0.244 | 0.183 | 0.447 | Antibacterial | 0.447 0.058 CID_49838 | CID_49838 | |
| 0.119 | 0.059 | 0.119 | Alpha 2b adrenoreceptor antagonist | |||
| 0.11 | 0.049 | 0.11 | Sphingomyelinase inhibitor | |||
| 0.069 | 0.008 | 0.069 | Geranyltranstransferase inhibitor | 0.049 0.024 CID_49838 | ||
| 0.083 | 0.023 | 0.083 | NMDA 2C receptor antagonist | |||
| 0.069 | 0.009 | 0.069 | Liver X receptor alpha agonist | |||
| 0.063 | 0.003 | 0.063 | Imidazoline I1 receptor antagonist | |||
| 0.065 | 0.005 | 0.065 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.084 | 0.025 | 0.084 | Protein kinase C beta inhibitor | |||
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | 0.054 0.048 CID_49838 | ||
| 0.094 | 0.034 | 0.094 | Interferon agonist | 0.072 0.067 CID_49838 | ||
| 0.068 | 0.008 | 0.068 | Benzodiazepine antagonist | |||
| 0.093 | 0.034 | 0.093 | Glutamate dehydrogenase inhibitor | 0.083 0.042 CID_49838 | ||
| 0.104 | 0.045 | 0.104 | Phosphodiesterase 6D inhibitor | 0.089 0.078 CID_49838 | ||
| 0.082 | 0.024 | 0.082 | Purinergic P2X1 antagonist | 0.07 0.032 CID_49838 | ||
| 0.098 | 0.039 | 0.098 | Acetylcholine nicotinic agonist | |||
| 0.085 | 0.027 | 0.085 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.087 | 0.029 | 0.087 | MAP kinase kinase 7 inhibitor | 0.077 0.056 CID_49838 | ||
| 0.107 | 0.049 | 0.107 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.062 | 0.005 | 0.062 | Free fatty acid receptor 1 antagonist | 0.038 0.018 CID_49838 | ||
| 0.073 | 0.016 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.081 | 0.023 | 0.081 | Androgen agonist | 0.077 0.025 CID_49838 | ||
| 0.064 | 0.007 | 0.064 | Nerve growth factor antagonist | |||
| 0.097 | 0.04 | 0.097 | Inducible nitric-oxide synthase inhibitor | |||
| 0.106 | 0.049 | 0.106 | Glutamate (mGluR7) agonist | |||
| 0.072 | 0.016 | 0.072 | Topoisomerase II beta inhibitor | 0.052 0.03 CID_49838 | ||
| 0.061 | 0.005 | 0.061 | Angiotensin AT1 receptor antagonist | |||
| 0.115 | 0.059 | 0.122 | Mucolytic | 0.122 0.053 CID_49838 | CID_49838 | |
| 0.142 | 0.087 | 0.142 | Protein-tyrosine phosphatase inhibitor | |||
| 0.109 | 0.053 | 0.109 | Xanthine oxidase inhibitor | |||
| 0.081 | 0.026 | 0.081 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.08 | 0.024 | 0.08 | Alpha 2 adrenoreceptor agonist | |||
| 0.078 | 0.023 | 0.078 | Acyl-CoA dehydrogenase inhibitor | 0.064 0.03 CID_49838 | ||
| 0.068 | 0.013 | 0.068 | Immunoglobulin Fc receptor antagonist | |||
| 0.184 | 0.129 | 0.245 | Hypoglycemic | 0.245 0.08 CID_49838 | CID_49838 | |
| 0.118 | 0.064 | 0.118 | Interleukin 8 antagonist | |||
| 0.082 | 0.028 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.08 0.029 CID_49838 | ||
| 0.085 | 0.03 | 0.085 | Acetylcholine M5 receptor agonist | |||
| 0.101 | 0.047 | 0.101 | Potassium channel activator | |||
| 0.09 | 0.036 | 0.09 | Glutamate decarboxylase inhibitor | |||
| 0.059 | 0.005 | 0.059 | Liver X receptor beta antagonist | |||
| 0.058 | 0.005 | 0.058 | Cholesterol ester transfer protein antagonist | 0.049 0.008 CID_49838 | ||
| 0.192 | 0.138 | 0.192 | Streptokinase A inhibitor | |||
| 0.086 | 0.033 | 0.086 | Carbonic anhydrase V inhibitor | |||
| 0.07 | 0.017 | 0.07 | 5 Hydroxytryptamine 1B agonist | |||
| 0.077 | 0.024 | 0.077 | Estrogen agonist | 0.06 0.03 CID_49838 | ||
| 0.059 | 0.006 | 0.059 | Retinoid X receptor antagonist | |||
| 0.1 | 0.048 | 0.1 | Calcium antagonist | |||
| 0.164 | 0.113 | 0.164 | Anticonvulsant | |||
| 0.066 | 0.015 | 0.078 | Glucose-6-phosphate isomerase inhibitor | 0.078 0.009 CID_49838 | CID_49838 | |
| 0.129 | 0.078 | 0.129 | Toll-Like receptor 9 antagonist | |||
| 0.068 | 0.018 | 0.068 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.091 | 0.04 | 0.091 | Caspase 7 inhibitor | |||
| 0.091 | 0.041 | 0.091 | Macrophage migration inhibitory factor inhibitor | |||
| 0.084 | 0.034 | 0.084 | Carbonic anhydrase VA inhibitor | |||
| 0.246 | 0.196 | 0.246 | MAP kinase kinase 6 inhibitor | |||
| 0.169 | 0.119 | 0.169 | Dyrk kinase inhibitor | |||
| 0.062 | 0.012 | 0.062 | Glutamate (mGluR group II) agonist | |||
| 0.065 | 0.015 | 0.065 | Potassium channel (Inward rectifier) activator | |||
| 0.136 | 0.086 | 0.136 | Thiol protease inhibitor | |||
| 0.055 | 0.006 | 0.055 | Melatonin receptor 1A agonist | |||
| 0.059 | 0.01 | 0.059 | Acid-sensing ion channel blocker | |||
| 0.09 | 0.041 | 0.09 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 CID_49838 | ||
| 0.132 | 0.083 | 0.132 | Cell wall synthesis inhibitor | 0.123 0.095 CID_49838 | ||
| 0.054 | 0.005 | 0.054 | Angiotensin II receptor antagonist | |||
| 0.093 | 0.045 | 0.093 | I kappa B kinase inhibitor | |||
| 0.119 | 0.07 | 0.119 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.078 | 0.029 | 0.078 | Orexin receptor antagonist | |||
| 0.075 | 0.027 | 0.075 | I kappa B kinase 2 inhibitor | |||
| 0.138 | 0.09 | 0.138 | MAP kinase kinase 4 inhibitor | |||
| 0.118 | 0.07 | 0.118 | Abl kinase inhibitor | |||
| 0.075 | 0.027 | 0.075 | MDM2 inhibitor | 0.066 0.049 CID_49838 | ||
| 0.056 | 0.008 | 0.056 | MAP3K5 inhibitor | |||
| 0.057 | 0.009 | 0.057 | 5 Hydroxytryptamine 2B agonist | |||
| 0.092 | 0.045 | 0.092 | Carbonic anhydrase VI inhibitor | |||
| 0.069 | 0.022 | 0.069 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.059 | 0.012 | 0.059 | Dopamine D5 agonist | |||
| 0.096 | 0.049 | 0.096 | Phosphodiesterase I inhibitor | |||
| 0.061 | 0.015 | 0.061 | Potassium channel (ATP-sensitive) activator | |||
| 0.058 | 0.011 | 0.058 | Glutamate (mGluR2) agonist | |||
| 0.24 | 0.194 | 0.244 | Alpha-glucosidase inhibitor | 0.244 0.191 CID_49838 | CID_49838 | |
| 0.062 | 0.016 | 0.062 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.07 | 0.024 | 0.07 | Nicotinic alpha7 receptor agonist | |||
| 0.083 | 0.037 | 0.083 | GABA B receptor agonist | |||
| 0.086 | 0.04 | 0.086 | Cathepsin G inhibitor | |||
| 0.066 | 0.021 | 0.066 | Dihydroorotate oxidase inhibitor | |||
| 0.074 | 0.028 | 0.074 | Argininosuccinate synthase inhibitor | 0.063 0.034 CID_49838 | ||
| 0.051 | 0.006 | 0.051 | Retinoid X alpha receptor antagonist | |||
| 0.18 | 0.135 | 0.18 | Calpain inhibitor | |||
| 0.075 | 0.03 | 0.075 | Aromatase inhibitor | |||
| 0.059 | 0.014 | 0.059 | Glutamate (mGluR group III) antagonist | |||
| 0.08 | 0.035 | 0.08 | Potassium channel (Tandem pore domain) blocker | |||
| 0.106 | 0.061 | 0.106 | Beta glucuronidase inhibitor | |||
| 0.062 | 0.018 | 0.062 | Aldosterone antagonist | |||
| 0.121 | 0.077 | 0.121 | Cyclooxygenase 3 inhibitor | |||
| 0.068 | 0.024 | 0.068 | Sphingosine kinase 2 inhibitor | 0.055 0.038 CID_49838 | ||
| 0.063 | 0.019 | 0.063 | CD45 antagonist | |||
| 0.102 | 0.059 | 0.102 | MAO B inhibitor | |||
| 0.107 | 0.064 | 0.107 | Falcipain 3 inhibitor | |||
| 0.072 | 0.029 | 0.072 | Phosphodiesterase 1B inhibitor | |||
| 0.071 | 0.028 | 0.071 | Cyclin D1 inhibitor | |||
| 0.057 | 0.015 | 0.057 | Urate transporter 1 inhibitor | |||
| 0.047 | 0.005 | 0.047 | Dopamine D1 agonist | 0.026 0.012 CID_49838 | ||
| 0.055 | 0.013 | 0.055 | Histamine H1 receptor agonist | |||
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.061 | 0.019 | 0.061 | Mineralocorticoid receptor antagonist | |||
| 0.05 | 0.008 | 0.05 | Complement C5a chemotactic receptor antagonist | |||
| 0.077 | 0.036 | 0.077 | Nav1.7 sodium channel blocker | |||
| 0.066 | 0.025 | 0.084 | Glucosylceramidase inhibitor | 0.084 0.014 CID_49838 | CID_49838 | |
| 0.051 | 0.01 | 0.051 | Liver X receptor beta agonist | |||
| 0.113 | 0.073 | 0.115 | Adenylate cyclase inhibitor | 0.115 0.072 CID_49838 | CID_49838 | |
| 0.104 | 0.064 | 0.14 | Expectorant | 0.14 0.04 CID_49838 | CID_49838 | |
| 0.054 | 0.014 | 0.054 | TRPM8 blocker | |||
| 0.052 | 0.012 | 0.052 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.052 | 0.013 | 0.052 | Retinoic acid alpha receptor agonist | |||
| 0.103 | 0.063 | 0.103 | Urease inhibitor | |||
| 0.075 | 0.036 | 0.075 | Dopamine D1 antagonist | |||
| 0.079 | 0.04 | 0.079 | Benzodiazepine agonist | |||
| 0.145 | 0.107 | 0.145 | Tumour necrosis factor antagonist | |||
| 0.057 | 0.019 | 0.057 | Sphingosine 1-phosphate receptor agonist | |||
| 0.102 | 0.064 | 0.117 | Gastric antisecretory | 0.117 0.045 CID_49838 | CID_49838 | |
| 0.069 | 0.031 | 0.069 | Transcription factor AP-1 inhibitor | |||
| 0.059 | 0.022 | 0.059 | Squalene epoxidase inhibitor | |||
| 0.041 | 0.004 | 0.041 | Alpha 2a adrenoreceptor agonist | |||
| 0.071 | 0.034 | 0.071 | Interferon inducer | |||
| 0.088 | 0.052 | 0.088 | Myeloperoxidase inhibitor | |||
| 0.051 | 0.014 | 0.051 | Diamine oxidase inhibitor | |||
| 0.072 | 0.036 | 0.072 | CDC25B inhibitor | |||
| 0.047 | 0.011 | 0.047 | Calcium release-activated channel blocker | |||
| 0.095 | 0.059 | 0.095 | Potassium channel (Voltage-sensitive) activator | |||
| 0.057 | 0.021 | 0.057 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.078 | 0.042 | 0.078 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.045 | 0.01 | 0.045 | HMG CoA reductase inhibitor | 0.042 0.012 CID_49838 | ||
| 0.046 | 0.011 | 0.046 | Melatonin agonist | |||
| 0.097 | 0.061 | 0.097 | MAP kinase kinase 1 inhibitor | |||
| 0.12 | 0.084 | 0.12 | Sodium channel blocker | |||
| 0.04 | 0.005 | 0.04 | Free fatty acid receptor 1 agonist | 0.018 0.012 CID_49838 | ||
| 0.039 | 0.004 | 0.039 | Complement factor 1s inhibitor | |||
| 0.074 | 0.04 | 0.074 | Potassium channel large-conductance Ca-activated activator | |||
| 0.059 | 0.025 | 0.059 | Potassium channel (Inward rectifier) blocker | |||
| 0.054 | 0.02 | 0.054 | Cytokine production stimulant | |||
| 0.071 | 0.037 | 0.071 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.093 | 0.06 | 0.093 | Protein kinase C zeta inhibitor | |||
| 0.046 | 0.012 | 0.046 | Vanilloid 3 antagonist | |||
| 0.063 | 0.03 | 0.063 | Prostaglandin antagonist | |||
| 0.035 | 0.003 | 0.035 | Progesterone receptor A antagonist | 0.01 0.006 CID_49838 | ||
| 0.119 | 0.086 | 0.119 | Toll-Like receptor antagonist | |||
| 0.079 | 0.047 | 0.079 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.056 | 0.024 | 0.056 | Potassium channel Kv1.3 blocker | |||
| 0.038 | 0.006 | 0.038 | Nicotinic acid receptor 2 antagonist | |||
| 0.048 | 0.017 | 0.048 | Glutamate (mGluR group II) antagonist | |||
| 0.07 | 0.038 | 0.07 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.074 | 0.043 | 0.074 | Secretase beta inhibitor | |||
| 0.05 | 0.019 | 0.05 | GABA B receptor antagonist | |||
| 0.079 | 0.048 | 0.079 | Phosphodiesterase 4D inhibitor | |||
| 0.048 | 0.017 | 0.048 | Kainate receptor agonist | 0.04 0.033 CID_49838 | ||
| 0.05 | 0.019 | 0.05 | Dihydrofolate reductase inhibitor | |||
| 0.058 | 0.027 | 0.058 | Heparanase inhibitor | 0.055 0.033 CID_49838 | ||
| 0.05 | 0.02 | 0.05 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.048 | 0.017 | 0.048 | Heme oxygenase inhibitor | |||
| 0.034 | 0.003 | 0.034 | Imidazoline I2 receptor antagonist | |||
| 0.1 | 0.07 | 0.1 | AMP-activated protein kinase stimulant | 0.09 0.085 CID_49838 | ||
| 0.072 | 0.042 | 0.072 | Protein kinase C alpha inhibitor | |||
| 0.07 | 0.04 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.098 | 0.068 | 0.098 | Alpha 2c adrenoreceptor antagonist | |||
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.247 | 0.218 | 0.571 | Apoptosis agonist | 0.571 0.056 CID_49838 | CID_49838 | |
| 0.041 | 0.012 | 0.041 | ATP citrate lysase inhibitor | 0.034 0.019 CID_49838 | ||
| 0.064 | 0.036 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.172 | 0.144 | 0.172 | Spasmolytic | |||
| 0.044 | 0.015 | 0.044 | Sirtuin 2 inhibitor | |||
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | 0.032 0.009 CID_49838 | ||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | |||
| 0.083 | 0.056 | 0.083 | Glutathione S-transferase inhibitor | |||
| 0.065 | 0.038 | 0.065 | TRPA1 antagonist | |||
| 0.061 | 0.034 | 0.061 | Nicotinic neuronal receptor agonist | |||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.031 | 0.004 | 0.031 | Retinoid X beta receptor antagonist | |||
| 0.066 | 0.04 | 0.066 | NMDA receptor glycine site agonist | |||
| 0.058 | 0.032 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.057 | 0.031 | 0.057 | Phosphodiesterase 4A inhibitor | |||
| 0.075 | 0.05 | 0.075 | Phosphodiesterase VI inhibitor | |||
| 0.04 | 0.015 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.065 | 0.039 | 0.065 | Cannabinoid CB1 receptor antagonist | |||
| 0.041 | 0.015 | 0.041 | Melatonin 2 agonist | |||
| 0.075 | 0.05 | 0.075 | MAP kinase 14 inhibitor | |||
| 0.036 | 0.011 | 0.036 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.043 | 0.018 | 0.043 | Glucocorticoid antagonist | |||
| 0.05 | 0.025 | 0.05 | Glutamate (mGluR5) agonist | |||
| 0.043 | 0.018 | 0.043 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.062 | 0.038 | 0.062 | Carbonic anhydrase stimulant | |||
| 0.084 | 0.061 | 0.084 | Acetylcholine agonist | |||
| 0.032 | 0.008 | 0.032 | Vanilloid 2 agonist | 0.026 0.016 CID_49838 | ||
| 0.065 | 0.041 | 0.065 | Glutamate (mGluR) agonist | |||
| 0.197 | 0.173 | 0.235 | Caspase 3 stimulant | 0.235 0.126 CID_49838 | CID_49838 | |
| 0.049 | 0.026 | 0.049 | Purinergic P2X4 antagonist | |||
| 0.039 | 0.016 | 0.039 | Melatonin 1 agonist | |||
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.033 | 0.01 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.018 CID_49838 | ||
| 0.06 | 0.037 | 0.06 | Protein kinase C theta inhibitor | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | |||
| 0.036 | 0.014 | 0.036 | Glutamate (mGluR2) antagonist | |||
| 0.036 | 0.013 | 0.036 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.072 | 0.049 | 0.072 | Histidine decarboxylase inhibitor | |||
| 0.041 | 0.019 | 0.041 | Orexin receptor 2 antagonist | |||
| 0.032 | 0.01 | 0.032 | Retinoid X gamma receptor agonist | |||
| 0.127 | 0.105 | 0.127 | Phospholipase A2 inhibitor | |||
| 0.102 | 0.081 | 0.102 | Anesthetic local | |||
| 0.03 | 0.008 | 0.03 | Retinoid X beta receptor agonist | |||
| 0.06 | 0.039 | 0.06 | Glutamate (mGluR1) antagonist | |||
| 0.031 | 0.009 | 0.031 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.113 | 0.092 | 0.113 | Antibacterial (Helicobacter pylori) | |||
| 0.06 | 0.038 | 0.06 | Botulinum neurotoxin type A inhibitor | |||
| 0.06 | 0.039 | 0.06 | Bcl-xL inhibitor | |||
| 0.026 | 0.005 | 0.026 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.059 | 0.039 | 0.059 | Ryanodine receptor antagonist | |||
| 0.026 | 0.006 | 0.026 | Progesterone receptor B antagonist | |||
| 0.074 | 0.054 | 0.074 | Carbonic anhydrase XIII inhibitor | |||
| 0.032 | 0.011 | 0.032 | Myristoyl transferase inhibitor | |||
| 0.124 | 0.104 | 0.143 | Insulin secretagoues | 0.143 0.082 CID_49838 | CID_49838 | |
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.1 | 0.081 | 0.1 | MAP kinase 13 inhibitor | |||
| 0.058 | 0.04 | 0.058 | Xanthine dehydrogenase inhibitor | |||
| 0.049 | 0.031 | 0.049 | Glutamate (mGluR group I) agonist | |||
| 0.034 | 0.016 | 0.034 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.041 | 0.023 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.105 | 0.087 | 0.105 | Calcium channel N-type blocker | |||
| 0.06 | 0.042 | 0.06 | Potassium channel (Ca-activated) blocker | |||
| 0.024 | 0.007 | 0.024 | Alpha 2c adrenoreceptor agonist | |||
| 0.052 | 0.035 | 0.052 | NMDA 2A receptor antagonist | |||
| 0.025 | 0.008 | 0.025 | Retinoic acid beta receptor agonist | |||
| 0.059 | 0.042 | 0.059 | Sphingosine kinase inhibitor | |||
| 0.095 | 0.078 | 0.095 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.058 | 0.042 | 0.058 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.036 | 0.02 | 0.036 | Adenosine uptake inhibitor | |||
| 0.034 | 0.018 | 0.034 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.029 | 0.014 | 0.054 | Sodium/glucose cotransporter 2 inhibitor | 0.054 0.006 CID_49838 | CID_49838 | |
| 0.095 | 0.08 | 0.095 | Monophenol monooxygenase inhibitor | |||
| 0.053 | 0.038 | 0.053 | Toll-Like receptor 8 antagonist | |||
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | 0.033 0.025 CID_49838 | ||
| 0.045 | 0.031 | 0.045 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.029 | 0.014 | 0.029 | Retinoid X gamma receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Progesterone agonist | |||
| 0.046 | 0.032 | 0.046 | Farnesyltransferase inhibitor | |||
| 0.136 | 0.122 | 0.136 | DNA methyltransferase I inhibitor | |||
| 0.026 | 0.012 | 0.026 | Geranylgeranyltransferase inhibitor | |||
| 0.062 | 0.048 | 0.062 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.039 | 0.025 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.03 | 0.016 | 0.03 | Estrogen-related receptor gamma antagonist | |||
| 0.102 | 0.088 | 0.102 | c-Src kinase inhibitor | |||
| 0.024 | 0.01 | 0.024 | Retinoic acid alpha receptor antagonist | |||
| 0.096 | 0.082 | 0.096 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | |||
| 0.127 | 0.114 | 0.127 | Polo-like kinase-3 inhibitor | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.026 | 0.013 | 0.026 | Retinoic acid receptor agonist | |||
| 0.041 | 0.028 | 0.041 | Thymidine kinase inhibitor | 0.037 0.036 CID_49838 | ||
| 0.149 | 0.136 | 0.149 | Potassium channel blocker | |||
| 0.1 | 0.087 | 0.1 | Proteasome inhibitor | |||
| 0.03 | 0.018 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 CID_49838 | ||
| 0.03 | 0.018 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.044 | 0.032 | 0.044 | Purinergic P2Y antagonist | 0.04 0.036 CID_49838 | ||
| 0.019 | 0.006 | 0.019 | Angiotensin AT1B receptor antagonist | |||
| 0.028 | 0.016 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 CID_49838 | ||
| 0.036 | 0.024 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 CID_49838 | ||
| 0.027 | 0.015 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.039 0.007 CID_49838 | CID_49838 | |
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.104 | 0.093 | 0.104 | Nav1.3 sodium channel blocker | |||
| 0.042 | 0.031 | 0.042 | Histamine H2 receptor agonist | |||
| 0.037 | 0.026 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.04 | 0.029 | 0.04 | Glutamate (mGluR1a) antagonist | |||
| 0.046 | 0.036 | 0.046 | Cholesterol esterase inhibitor | |||
| 0.051 | 0.04 | 0.075 | Alpha tubulin antagonist | 0.075 0.022 CID_49838 | CID_49838 | |
| 0.023 | 0.012 | 0.023 | Angiotensin AT1A receptor antagonist | |||
| 0.072 | 0.062 | 0.072 | Fibroblast growth factor 3 antagonist | |||
| 0.108 | 0.098 | 0.108 | Bone formation stimulant | |||
| 0.029 | 0.019 | 0.029 | 5 Hydroxytryptamine 6 agonist | |||
| 0.037 | 0.027 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.027 | 0.017 | 0.027 | Calcium-sensing receptor agonist | |||
| 0.098 | 0.089 | 0.098 | Activin receptor-like kinase 4 inhibitor | |||
| 0.02 | 0.01 | 0.02 | Apolipoprotein B-100 inhibitor | |||
| 0.02 | 0.011 | 0.02 | Retinoic acid receptor antagonist | |||
| 0.021 | 0.012 | 0.021 | Apolipoprotein B inhibitor | |||
| 0.052 | 0.043 | 0.052 | Bromodomain-containing protein 4 inhibitor | |||
| 0.028 | 0.018 | 0.028 | Glucosylceramidase stimulant | |||
| 0.015 | 0.006 | 0.015 | Cyclin D2 inhibitor | |||
| 0.036 | 0.027 | 0.036 | Integrin alpha2 antagonist | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.023 | 0.014 | 0.023 | Adenosine kinase inhibitor | 0.019 0.018 CID_49838 | ||
| 0.051 | 0.042 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.036 CID_49838 | CID_49838 | |
| 0.015 | 0.006 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.065 | 0.056 | 0.092 | HIV-1 integrase inhibitor | 0.092 0.03 CID_49838 | CID_49838 | |
| 0.087 | 0.079 | 0.087 | MAP kinase kinase kinase inhibitor | |||
| 0.047 | 0.038 | 0.047 | Dopamine beta hydroxylase inhibitor | |||
| 0.051 | 0.043 | 0.051 | Lysine-specific demethylase 1A inhibitor | |||
| 0.036 | 0.028 | 0.036 | Farnesoid X receptor agonist | 0.033 0.032 CID_49838 | ||
| 0.035 | 0.027 | 0.035 | Glutamate (mGluR3) antagonist | |||
| 0.053 | 0.045 | 0.053 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.026 | 0.018 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.021 | 0.013 | 0.021 | Toll-Like receptor 8 agonist | |||
| 0.041 | 0.034 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.055 | 0.047 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.058 | 0.05 | 0.058 | NMDA receptor agonist | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.047 | 0.039 | 0.047 | Dopamine D4 agonist | |||
| 0.051 | 0.043 | 0.051 | Leukotriene B4 antagonist | 0.05 0.043 CID_49838 | ||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.031 | 0.024 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.036 | 0.029 | 0.036 | NMDA receptor subunit 3A antagonist | |||
| 0.041 | 0.034 | 0.041 | NMDA receptor subunit 3B antagonist | |||
| 0.088 | 0.081 | 0.088 | Insulin receptor antagonist | |||
| 0.018 | 0.011 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.023 | 0.016 | 0.023 | Prostaglandin D2 antagonist | |||
| 0.121 | 0.114 | 0.121 | Sigma receptor agonist | |||
| 0.014 | 0.007 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.022 | 0.015 | 0.022 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.022 | 0.016 | 0.022 | Retinoic acid gamma receptor agonist | |||
| 0.019 | 0.013 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_49838 | CID_49838 | |
| 0.074 | 0.068 | 0.074 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.064 | 0.058 | 0.064 | Cannabinoid receptor antagonist | |||
| 0.054 | 0.048 | 0.054 | Leukotriene C antagonist | |||
| 0.025 | 0.019 | 0.025 | Complement factor 1r inhibitor | |||
| 0.029 | 0.023 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.083 | 0.077 | 0.083 | Uric acid excretion stimulant | |||
| 0.013 | 0.007 | 0.013 | Egl nine homolog 3 inhibitor | |||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.065 | 0.06 | 0.065 | Calcium channel L-type blocker | |||
| 0.049 | 0.044 | 0.049 | Acetyl-CoA transferase inhibitor | |||
| 0.116 | 0.11 | 0.116 | Diuretic | |||
| 0.052 | 0.047 | 0.052 | Kallikrein 1 inhibitor | |||
| 0.017 | 0.012 | 0.017 | Telomerase stimulant | 0.017 0.011 CID_49838 | ||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.045 | 0.04 | 0.045 | Cannabinoid CB2 receptor antagonist | |||
| 0.031 | 0.026 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.082 | 0.077 | 0.082 | Breast cancer-resistant protein inhibitor | |||
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.017 | 0.012 | 0.017 | G-protein-coupled receptor 120 agonist | |||
| 0.045 | 0.04 | 0.045 | Histamine H4 receptor antagonist | |||
| 0.094 | 0.09 | 0.094 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.031 | 0.027 | 0.031 | Glutamate (mGluR3) agonist | |||
| 0.033 | 0.03 | 0.033 | Nicotinic acid receptor agonist | |||
| 0.08 | 0.077 | 0.171 | ATPase (Vacuolar H+) inhibitor | 0.171 0.004 CID_49838 | CID_49838 | |
| 0.038 | 0.036 | 0.038 | Sphingosine kinase 1 inhibitor | |||
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.049 | 0.047 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.05 | 0.049 | 0.05 | Epithelial sodium channel blocker | |||
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.134 | 0.133 | 0.134 | DNA methylase inhibitor | |||
| 0.075 | 0.074 | 0.075 | Alpha 2 adrenoreceptor antagonist | |||
| 0.085 | 0.084 | 0.136 | Topoisomerase I inhibitor | 0.136 0.047 CID_49838 | CID_49838 | |
| 0.05 | 0.049 | 0.05 | Dopamine uptake inhibitor | |||
| 0.098 | 0.1 | 0.105 | Interleukin 2 antagonist | 0.105 0.076 CID_49838 | CID_49838 | |
| 0.012 | 0.02 | 0.015 | Thromboxane A2 agonist | 0.015 0.012 CID_49838 | CID_49838 | |
| 0.037 | 0.046 | 0.041 | Mannosidase inhibitor | 0.041 0.039 CID_49838 | CID_49838 | |
| 0.219 | 0.248 | 0.351 | Cyclophilin D inhibitor | 0.351 0.122 CID_49838 | CID_49838 | |
| 0.063 | 0.097 | 0.103 | Antineoplastic alkaloid | 0.103 0.045 CID_49838 | CID_49838 | |
| 0.124 | 0.161 | 0.147 | P-glycoprotein inhibitor | 0.147 0.122 CID_49838 | CID_49838 | |
| 0.14 | 0.178 | 0.304 | Antioxidant | 0.304 0.06 CID_49838 | CID_49838 | |
| 0.132 | 0.173 | 0.17 | Immunostimulant | 0.17 0.139 CID_49838 | CID_49838 | |
| 0.234 | 0.285 | 0.408 | Antiinflammatory | 0.408 0.135 CID_49838 | CID_49838 | |
| 0.078 | 0.133 | 0.113 | Tubulin antagonist | 0.113 0.087 CID_49838 | CID_49838 | |
| 0.04 | 0.099 | 0.288 | Antineoplastic antibiotic | 0.288 0.01 CID_49838 | CID_49838 | |
| 0.045 | 0.113 | 0.084 | Topoisomerase II alpha inhibitor | 0.084 0.05 CID_49838 | CID_49838 | |
| 0.102 | 0.172 | 0.221 | Nitric oxide antagonist | 0.221 0.06 CID_49838 | CID_49838 | |
| 0.037 | 0.107 | 0.072 | HIV-1 integrase (3'-Processing) inhibitor | 0.072 0.037 CID_49838 | CID_49838 | |
| 0.113 | 0.203 | 0.16 | Free radical scavenger | 0.16 0.134 CID_49838 | CID_49838 | |
| 0.069 | 0.177 | 0.145 | Lipid peroxidase inhibitor | 0.145 0.072 CID_49838 | CID_49838 | |
| 0.024 | 0.135 | 0.151 | HIV-1 integrase (Strand Transfer) inhibitor | 0.151 0.013 CID_49838 | CID_49838 | |
| 0.051 | 0.167 | 0.233 | Topoisomerase II inhibitor | 0.233 0.027 CID_49838 | CID_49838 | |
| 0.087 | 0.236 | 0.131 | Interleukin 6 antagonist | 0.131 0.123 CID_49838 | CID_49838 | |
| 0.088 | 0.291 | 0.15 | Lipocortins synthesis antagonist | 0.15 0.105 CID_49838 | CID_49838 | |
| 0.057 | 0.371 | 0.171 | Hepatoprotectant | 0.171 0.088 CID_49838 | CID_49838 | |
| 0.043 | 0.41 | 0.244 | Antimitotic | 0.244 0.062 CID_49838 | CID_49838 | |
| 0.03 | 0.399 | 0.054 | Lipocortins synthesis agonist | 0.054 0.052 CID_49838 | CID_49838 | |
| 0.01 | 0.519 | 0.052 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 CID_49838 | CID_49838 | |
| 0.058 | 0.831 | 0.246 | Peptidyltransferase inhibitor | 0.246 0.053 CID_49838 | CID_49838 | |
| 0.003 | 0.918 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 CID_49838 | CID_49838 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |